Recent Episodes
In the next three decades, an additional ten million people will die from multi drug-resistant bacteria. One solution to this monumental problem is to create new antibiotics but that can take a decade to develop and approve. Another, more efficient solution, is to optimize the use of current antibiotics.
Using this approach, a novel solution involves something called quantum dots which makes bacteria more susceptible to existing antibiotics. These quantum dots are made of a chemical called cadmium telluride. The molecules are about the width of a strand of DNA which is three nanometers or one fifteenth thousandths the thickness of a sheet of paper.
When these particles are exposed to green light, they lose electrons. The charged subatomic particles then interact with oxygen to form a very reactive molecule called superoxide. Bacteria that interact with these superoxides become damaged which makes them one thousand times more vulnerable to antibiotics. In experiments, the quantum dots were effective against a number of serious disease-causing bacteria including MRSA, Salmonella, Klebsiella and E.coli.
One major weakness of the therapy is that the green light can only penetrate a few millimeters into the skin and tissue so scientists are looking for alternate types of light that can penetrate deeply into tissue and organs. Time will tell if quantum dots will be the lifesaver we need as bacterial superbugs continue to find their way around our arsenal of antibiotics.
More Information
Superbugs may have met there match in these nanoparticles
Antibiotics may have a new teammate in the fight against drug-resistant infections. Researchers have engineered nanoparticles to produce chemicals that render bacteria more vulnerable to antibiotics. These quantum dots, described online October 4 in Science Advances, could help combat pathogens that have developed resistance to antibiotics...
Antibiotic Resistance: Coordinating a global response to counter the emergence of antibiotic-resistant bacteria.
Drug-resistant strains of bacteria are prevalent in both hospital and community settings; they cause billions of dollars in avoidable health costs and cause unnecessary disability and death. If left unaddressed, antibiotic resistance could recreate a world in which invasive surgeries are impossible and people routinely die from simple bacterial infections...
Dramatic rise seen in antibiotic use
Antibiotic use is growing steadily worldwide, driven mainly by rising demand in low- and middle-income countries, according to a report released on 17 September. The research presents the clearest picture yet of how and where the drugs are used, and the prevalence of different types of antibiotic resistance...
Medicine...
Medicine is constantly advancing – that is a great thing about life in the 21st century. But it doesn’t just happen. Dedicated biomedical scientists are making discoveries that translate into those new medical advances.
Biomedical science is broad, encompassing everything from social science to microbiology, biochemistry, epidemiology, to structural biology and bioinformatics to name just a few areas. And, it can involve basic fundamental biology, the use of AI and chemistry to clinical studies that evaluate new medicines in patients.
No matter the research focus, the goal is always the same, to advance human health. It may take a few months, a few years or for fundamental science, a few decades. Few people make the connection that biomedical science is medicine and that biomedical scientists are working today on the medicine of tomorrow. Our weekly 500-word newspaper columns and 2-minute radio shows and podcasts provide insights into a broad range of biomedical science topics.
Medical Discovery News is dedicated to explaining discoveries in biomedical research and their promise for the future of medicine.